Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 3/20 | 0.38 |
| ▸ | PTPN7 | P35236 | 5/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | RECQL | P46063 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 2/20 | 0.33 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL588584 | 0.83 | TSHR (0.39) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL2121918 | 0.77 | PTPN7 (0.40) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL9628541 | 0.74 | PTPN7 (0.43) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL31519146 | 0.74 | PTPN7 (0.43) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL3796992 | 0.74 | PTPN7 (0.43) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL3796995 | 0.74 | PTPN7 (0.43) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL9336077 | 0.74 | PTPN7 (0.43) | HMGCRPTPN7RECQLTDP1KDM4E | |
| SCHEMBL5865499 | 0.74 | PTPN7 (0.43) | HMGCRPTPN7RECQLTDP1KDM4E | |
| Oxalic Acid SCHEMBL5369747 | 0.73 | CA4 (0.41) | CA1 | |
| SCHEMBL14760330 | 0.72 | HMGCR (0.40) | HMGCRPTPN7RECQLTDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7169947-B2 | Dicopper(I) oxalate complexes for use as precursor substances in metallic copper deposition | BASF AKTIENGESELLISCHAFT (DE) | 2007-01-30 | — | — | US | claimed |
| US-20050226997-A1 | Dicopper(I)oxalate complexes for use as precursor substances in metallic copper deposition | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-13 | — | — | US | claimed |
| US-7169947-B2 | Dicopper(I) oxalate complexes for use as precursor substances in metallic copper deposition | BASF AKTIENGESELLISCHAFT (DE) | 2007-01-30 | — | — | US | disclosed |
| US-20050226997-A1 | Dicopper(I)oxalate complexes for use as precursor substances in metallic copper deposition | BASF AKTIENGESELLSCHAFT (DE) | 2005-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050226997-A1 | Dicopper(I)oxalate complexes for use as precursor substances in metallic copper deposition | AOC1, PDXK, OAT | HMGCR 3403/4885PTPN7 1531/4885CA1 235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.